SCHEMBL443374

SCHEMBL443374

C=C(C)C(=O)NCCC[Si](C)(C)O[Si](C)(C)C

nearest known ligand 0.34

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.32
MAPK1 P28482 1/20 0.32
HIF1A Q16665 1/20 0.32
ACHE P22303 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10754926 0.95 KDM4E (0.35) KDM4EMAPK1HIF1AACHE
SCHEMBL12094903 0.93 KDM4E (0.34) KDM4EMAPK1HIF1AACHE
SCHEMBL12373211 0.90 KDM4E (0.32) KDM4EMAPK1HIF1AACHE
SCHEMBL15828189 0.88 KDM4E (0.31) KDM4EMAPK1HIF1AACHE
SCHEMBL26259471 0.88 KDM4E (0.31) KDM4EMAPK1HIF1AACHE
SCHEMBL12222638 0.88 KDM4E (0.38) KDM4EMAPK1HIF1AACHE
SCHEMBL263454 0.86 KDM4E (0.32) KDM4EMAPK1HIF1AACHE
SCHEMBL441807 0.86 KDM4E (0.32) KDM4EMAPK1HIF1AACHE
SCHEMBL26688049 0.85
SCHEMBL514781 0.85 KDM4E (0.31) KDM4EMAPK1HIF1AACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10745518-B2 Branching-type polyoxyethylene compound and contact lens NOF CORPORATION (JP) 2020-08-18 US disclosed
US-20190106539-A1 BRANCHING-TYPE POLYOXYETHYLENE COMPOUND AND CONTACT LENS NOF CORPORATION (JP) 2019-04-11 US disclosed
US-9056880-B2 Process for producing hydrolysis-resistant silicone compounds JOHNSON & JOHNSON VISION CARE, INC. (US) 2015-06-16 US disclosed
US-8921449-B2 Hydrolysis-resistant silicone compounds JOHNSON & JOHNSON VISION CARE INC. (US) 2014-12-30 US disclosed
US-20140128564-A1 PROCESS FOR PRODUCING HYDROLYSIS-RESISTANT SILICONE COMPOUNDS FUJISAWA KAZUHIKO (JP) 2014-05-08 US disclosed
US-8637589-B2 Silicone prepolymer solutions JOHNSON & JOHNSON VISION CARE, INC. (US) 2014-01-28 US disclosed
US-8569538-B2 Acryloyl materials for molded plastics JOHNSON & JOHNSON VISION CARE, INC. (US) 2013-10-29 US disclosed
US-8481608-B2 Silicone monomer NOF CORPORATION (JP) 2013-07-09 US disclosed
US-20130131298-A1 HYDROLYSIS-RESISTANT SILICONE COMPOUNDS TORAY INDUSTRIES, INC. (JP) 2013-05-23 US disclosed
US-8399539-B2 Soluble silicone prepolymers JOHNSON & JOHNSON VISION CARE, INC. (US) 2013-03-19 US disclosed
US-8053539-B2 Prepared by purifying acrylic siloxanyl containing monomers by distillation in the presence of at least one polymerization inhibitor which can be an alkylhydroquinone or a hydroxynaphthalene; without substantial amounts of polymerization product(s) and without discoloration; contact lenses JOHNSON & JOHNSON VISION CARE INC. (US) 2011-11-08 US disclosed
US-20110077322-A1 Silicone Prepolymer Solutions TORAY INDUSTRIES, INC. (JP) 2011-03-31 US disclosed
US-7897654-B2 Silicone prepolymer solutions JOHNSON & JOHNSON VISION CARE INC. (US) 2011-03-01 US disclosed
US-20110028673-A1 HYDROLYSIS-RESISTANT SILICONE COMPOUNDS JOHNSON & JOHNSON VISION CARE, INC. 2011-02-03 US disclosed
US-20090171026-A1 SILICONE PREPOLYMER SOLUTIONS JOHNSON & JOHNSON VISION CARE, INC. 2009-07-02 US disclosed
US-20090005528-A1 SOLUBLE SILICONE PREPOLYMERS JOHNSON & JOHNSON VISION CARE, INC. 2009-01-01 US disclosed
US-20080081850-A1 Such as reaction of butyldimethylsilanol with 3-trichlorosilylpropyl methacrylate to produce 3-[tris(butyldimethylsiloxy)silyl]propyl methacrylate; steric hindrance, purity; copolymers with acrylate endcapped polysiloxane and acrylic monomers; contact and intraocular lenses, artificial cornea JOHNSON & JOHNSON VISION CARE, INC. 2008-04-03 US disclosed
US-7317117-B2 Siloxanyl-containing monomers JOHNSON & JOHNSON VISION CARE, INC. (US) 2008-01-08 US disclosed
US-20080004401-A1 SILOXANYL MATERIALS FOR MOLDED PLASTICS JOHNSON & JOHNSON VISION CARE, INC. 2008-01-03 US disclosed
US-20080004383-A1 ACRYLOYL MATERIALS FOR MOLDED PLASTICS TORAY INDUSTRIES, INC. (JP) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140128564-A1 PROCESS FOR PRODUCING HYDROLYSIS-RESISTANT SILICONE COMPOUNDS LSS, PIGS, STS KDM4E 1904/4885MAPK1 2705/4885HIF1A 4156/4885
US-20090005528-A1 SOLUBLE SILICONE PREPOLYMERS NOS3, NOS2, PCNA KDM4E 3647/4885MAPK1 3212/4885HIF1A 73/4885
US-20080004383-A1 ACRYLOYL MATERIALS FOR MOLDED PLASTICS ACR, HAAO, PORCN KDM4E 1956/4885MAPK1 4110/4885HIF1A 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.